Advanced chondrosarcomas: role of chemotherapy and survival. (Q37265042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Advanced chondrosarcomas: role of chemotherapy and survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Angela Cioffi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Angela Cioffi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Emanuela Palmerini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Nicolas Penel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Robert G. Maki

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jean-Yves Blay

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

17

I Ray Coquard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

A Italiano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

S Piperno-Neumann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

C Perrin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

L Chaigneau

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

F Duffaud

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

J E Kurtz

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

O Collard

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

F Bertucci

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

E Bompas

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

A Le Cesne

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

7 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

2916-2922

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study

27 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Inhibition of chondrosarcoma growth by mTOR inhibitor in an in vivo syngeneic rat model

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Chondrosarcoma and peroxisome proliferator-activated receptor

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Randomized comparison of doxorubicin and vindesine to doxorubicin for patients with metastatic soft-tissue sarcomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Dedifferentiated chondrosarcoma

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3811906

Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

14 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT374

Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading

21 January 2018

1 reference

12 December 2020

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma

1 reference

12 December 2020

Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance

1 reference

12 December 2020

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

12 December 2020

Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups

1 reference

12 December 2020

Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDT374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

PubMed publication ID

24099780

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24099780%20AND%20SRC:MED&resulttype=core&format=json